Voyageur PharmaceuticalsVYYRF 18 Days Inventory is 439.96 as of Feb. 2026, which is 75% below its 10-year median of 1,764.17. GuruFocus rates VYYRF with a GF Score™ of 18/100. The stock has 5 warning signs investors should review. Among 917 Drug Manufacturers companies, Voyageur Pharmaceuticals ranks worse than 98.69% on this metric.
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Voyageur Pharmaceuticals's Inventory Turnover for the
three
months ended in Feb. 2026 was 0.21.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Voyageur Pharmaceuticals's Inventory-to-Revenue for the
three
months ended in Feb. 2026 was 4.82.
Voyageur Pharmaceuticals (OTCPK:VYYRF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Voyageur Pharmaceuticals's Inventory Turnover for the
three
months ended in Feb. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Voyageur Pharmaceuticals's Inventory to Revenue for the
three
months ended in Feb. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Voyageur Pharmaceuticals Days Inventory Related Terms
Voyageur Pharmaceuticals Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Voyageur Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Voyageur Pharmaceuticals Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Voyageur Pharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where Voyageur Pharmaceuticals's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Voyageur Pharmaceuticals (VYYRF) has a Days Inventory of 439.96 as of Feb. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Voyageur Pharmaceuticals and its competitors. This is 75% below median its historical median of 1,764.17. Over the past decade, Voyageur Pharmaceuticals' Days Inventory has ranged from 1,156.23 to 1,764.17. According to the industry distribution chart, Voyageur Pharmaceuticals ranks #905 out of 917 companies in the Drug Manufacturers industry, placing it in the top 98.7%.
Is Voyageur Pharmaceuticals' Days Inventory too high?
Voyageur Pharmaceuticals' current Days Inventory of 439.96 is 75% below median its 10-year median of 1,764.17. Over the past 10 years, this metric has ranged from a low of 1,156.23 to a high of 1,764.17. The Drug Manufacturers industry median Days Inventory is 164.48. Voyageur Pharmaceuticals' value of 439.96 is 167.5% above this industry median. Based on the distribution chart, Voyageur Pharmaceuticals ranks #905 out of 917 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Voyageur Pharmaceuticals has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Voyageur Pharmaceuticals' Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Voyageur Pharmaceuticals ranks #905 out of 917 companies for Days Inventory. This places Voyageur Pharmaceuticals in the lower half of its industry. The industry median Days Inventory is 164.48. Voyageur Pharmaceuticals' value of 439.96 is 167.5% above this benchmark. Historically, Voyageur Pharmaceuticals' own Days Inventory has ranged from 1,156.23 to 1,764.17 over the past decade. While the company's 10-year median is 1,764.17 vs. the industry median of 164.48, Voyageur Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 917 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Voyageur Pharmaceuticals's current Days Inventory of 439.96 is 167.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Voyageur Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Voyageur Pharmaceuticals's current Days Inventory is 439.96, which is 75% below median its own 10-year median of 1,764.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Voyageur Pharmaceuticals stock overvalued right now?
Voyageur Pharmaceuticals (VYYRF) has a current Days Inventory of 439.96. The current Days Inventory is 439.96, which is 75% below median its 10-year median of 1,764.17 and 167.5% above the Drug Manufacturers industry median of 164.48. Voyageur Pharmaceuticals' overall GF Score™ is 18/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Voyageur Pharmaceuticals (VYYRF), the current Days Inventory is 439.96 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Voyageur Pharmaceuticals Ltd is a Canadian development-stage pharmaceutical company developing and selling barium and iodine active pharmaceutical ingredients (API) and high-performance, cost-effective imaging contrast agents for medical radiology. Its product portfolio comprises SmoothX (a barium sulfate suspension), SmoothHD, SmoothLD (a low-density barium suspension solution), VisionHD (a high-density barium powder suspension), VisionLD, V-Gas, and others. Additionally, the company has interests in two mineral properties: Frances Creek and Jubilee Mountain, located in the province of British Columbia, Canada, and the ULI Project in the state of Utah, United States of America.
18GF Score
Get the complete analysis for VYYRF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VYYRF has been successfully added to your 
